187 related articles for article (PubMed ID: 24275691)
21. The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes.
Petrelli A; Popp SK; Fukuda R; Parish CR; Bosi E; Simeonovic CJ
Front Immunol; 2022; 13():930553. PubMed ID: 35874740
[TBL] [Abstract][Full Text] [Related]
22. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
23. The proinflammatory effects of macrophage-derived NADPH oxidase function in autoimmune diabetes.
Feduska JM; Tse HM
Free Radic Biol Med; 2018 Sep; 125():81-89. PubMed ID: 29723665
[TBL] [Abstract][Full Text] [Related]
24. A new look at viruses in type 1 diabetes.
Jun HS; Yoon JW
Diabetes Metab Res Rev; 2003; 19(1):8-31. PubMed ID: 12592641
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune mechanisms in type 1 diabetes.
Knip M; Siljander H
Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
[TBL] [Abstract][Full Text] [Related]
26. The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.
Citro A; Cantarelli E; Piemonti L
Curr Diab Rep; 2015 Oct; 15(10):68. PubMed ID: 26275440
[TBL] [Abstract][Full Text] [Related]
27. Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA; Tritt M; Sgouroudis E; Albanese A; Pyzik M; Hay V
Ann N Y Acad Sci; 2005 Jun; 1051():72-87. PubMed ID: 16126946
[TBL] [Abstract][Full Text] [Related]
28. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
29. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
Khadra A; Santamaria P; Edelstein-Keshet L
J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil Extracellular Trap Induced Dendritic Cell Activation Leads to Th1 Polarization in Type 1 Diabetes.
Parackova Z; Zentsova I; Vrabcova P; Klocperk A; Sumnik Z; Pruhova S; Petruzelkova L; Hasler R; Sediva A
Front Immunol; 2020; 11():661. PubMed ID: 32346380
[TBL] [Abstract][Full Text] [Related]
31. Distinct neutrophil counts and functions in newly diagnosed type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes.
Huang J; Xiao Y; Zheng P; Zhou W; Wang Y; Huang G; Xu A; Zhou Z
Diabetes Metab Res Rev; 2019 Jan; 35(1):e3064. PubMed ID: 30123986
[TBL] [Abstract][Full Text] [Related]
32. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
[TBL] [Abstract][Full Text] [Related]
33. Thymus and type 1 diabetes: an update.
Geenen V
Diabetes Res Clin Pract; 2012 Oct; 98(1):26-32. PubMed ID: 22717497
[TBL] [Abstract][Full Text] [Related]
34. Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes.
Burg AR; Tse HM
Antioxid Redox Signal; 2018 Nov; 29(14):1373-1398. PubMed ID: 29037052
[TBL] [Abstract][Full Text] [Related]
35. NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count.
Qin J; Fu S; Speake C; Greenbaum CJ; Odegard JM
Clin Exp Immunol; 2016 Jun; 184(3):318-22. PubMed ID: 26939803
[TBL] [Abstract][Full Text] [Related]
36. Intracytoplasmic cytokine levels and neutrophil functions in early clinical stage of type 1 diabetes.
Bilgic S; Aktas E; Salman F; Ersahin G; Erten G; Yilmaz MT; Deniz G
Diabetes Res Clin Pract; 2008 Jan; 79(1):31-6. PubMed ID: 17707941
[TBL] [Abstract][Full Text] [Related]
37. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
38. Enteroviral pathogenesis of type 1 diabetes.
Hober D; Sane F
Discov Med; 2010 Aug; 10(51):151-60. PubMed ID: 20807476
[TBL] [Abstract][Full Text] [Related]
39. Emerging immune therapies in type 1 diabetes and pancreatic islet transplantation.
Schneider DA; Kretowicz AM; von Herrath MG
Diabetes Obes Metab; 2013 Jul; 15(7):581-92. PubMed ID: 23194064
[TBL] [Abstract][Full Text] [Related]
40. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
